Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (211-220 of 910) with videos related to

Pageof 91
Sort By:
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
American Heart Journal|January 29, 2013
Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialManesh R Patel, Cynthia M Westerhout, Christopher B Granger, et al.
American Heart Journal|September 11, 2013
Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE TrialJohn H Alexander, Elliott Levy, Jack Lawrence, et al.
Stroke|January 28, 2021
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUSHans-Christoph Diener, Aurauma Chutinet, J Donald Easton, et al.
The Journal of Nursing Administration|September 12, 2022
Health System Redesign of Cardiac Monitoring Oversight to Optimize Alarm Management, Safety, and Staff EngagementJill R Engel, Mary Lindsay, Stacey O'Brien, et al.
The American Journal of Emergency Medicine|September 10, 2010
Hypertensive heart failure: patient characteristics, treatment, and outcomesFrank Peacock, Alpesh Amin, Christopher B Granger, et al.
The American Journal of Cardiology|March 14, 2007
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shockRajendra H Mehta, Robert M Califf, Qinghong Yang, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
European Heart Journal|May 10, 2011
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trialJonas Oldgren, Andrzej Budaj, Christopher B Granger, et al.
Pageof 91

Showing results (211-220 of 910) with videos related to

Sort By:
Pageof 91
Journal of Thrombosis and Thrombolysis|June 22, 2016
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarctionSean van Diepen, Wendimagegn G Alemayehu, Yinggan Zheng, et al.
American Heart Journal|January 29, 2013
Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialManesh R Patel, Cynthia M Westerhout, Christopher B Granger, et al.
American Heart Journal|September 11, 2013
Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE TrialJohn H Alexander, Elliott Levy, Jack Lawrence, et al.
Stroke|January 28, 2021
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUSHans-Christoph Diener, Aurauma Chutinet, J Donald Easton, et al.
The Journal of Nursing Administration|September 12, 2022
Health System Redesign of Cardiac Monitoring Oversight to Optimize Alarm Management, Safety, and Staff EngagementJill R Engel, Mary Lindsay, Stacey O'Brien, et al.
The American Journal of Emergency Medicine|September 10, 2010
Hypertensive heart failure: patient characteristics, treatment, and outcomesFrank Peacock, Alpesh Amin, Christopher B Granger, et al.
The American Journal of Cardiology|March 14, 2007
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shockRajendra H Mehta, Robert M Califf, Qinghong Yang, et al.
American Heart Journal|June 25, 2004
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUITWei-Ching Chang, Eric Boersma, Christopher B Granger, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
European Heart Journal|May 10, 2011
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trialJonas Oldgren, Andrzej Budaj, Christopher B Granger, et al.
Pageof 91